)
The aim of this partnership is to make the analysis of patient samples using MADx's state-of-the-art ALEX² allergy test more widely available and to give even more doctors the opportunity to benefit from this innovative technology.
As a molecular allergy test, ALEX² is the leading blood test in its category and is characterised by the largest range of allergens tested (up to 300 in one step). The ALEX² test has already been used over 1 million times worldwide since the end of 2019.